Screening for CDKN2A mutations in hereditary melanoma.
Open Access
- 21 May 1997
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (10) , 676-678
- https://doi.org/10.1093/jnci/89.10.676
Abstract
Cutaneous malignant melanoma (CMM) is a potentially fatal form of skin cancer whose etiology is heterogeneous and complex. Approximately 10% of the cases of CMM occur in persons with a familial predisposition (1), often in association with clinically dysplastic or atypical nevi (2).Keywords
This publication has 19 references indexed in Scilit:
- Familial Melanoma and Pancreatic CancerNew England Journal of Medicine, 1996
- Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindredsNature Genetics, 1995
- Germline p16 mutations in familial melanomaNature Genetics, 1994
- Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusNature Genetics, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22Science, 1992
- Homozygous deletions within human chromosome band 9p21 in melanoma.Proceedings of the National Academy of Sciences, 1992
- Chromosomal evolution in the progression and metastasis of human malignant melanoma a multiple lesion studyCancer Genetics and Cytogenetics, 1989
- Cytogenetic Analysis of Melanocytes From Premalignant Nevi and MelanomasJNCI Journal of the National Cancer Institute, 1988